All treatments
Treatment
ELTROMBOPAG OLAMINE clinical trials
2 indexed studies · 0 currently recruiting
- Ongoing, recruitingHuman Pharmacology (Phase I)- Bioequivalence Study
Bioequivalence of Eltrombopag 75 mg Film-Coated Tablets: A Single-Dose, Open-Label, Randomized, Two-Sequence, Two-Treatment, Two-Period Crossover Study in Healthy Subjects Under Fed Conditions.
This study is testing if two different versions of a medicine called Eltrombopag work the same way in healthy people. Eltrombopag is used for blood conditions like aplastic anemia and thrombocytopenia. Researchers are checking how the body absorbs and processes the medicine.
For: Aplastic anemia · ThrombocytopeniaPortugal - Ongoing, recruitingHuman Pharmacology (Phase I)- Bioequivalence Study
Bioequivalence of Eltrombopag 75 mg Film-Coated Tablets: A Single-Dose, Open-Label, Randomized, Two-Sequence, Two-Treatment, Two-Period Crossover Study in Healthy Subjects Under Fasting Conditions.
This study checks if a new version of Eltrombopag, a medicine for blood disorders like low platelet count, works the same way in the body as the existing one. Healthy people take a single dose, and doctors measure how the drug is absorbed and leaves the body.
For: Thrombocytopenia · Aplastic anemiaPortugal